PubMed ID

15684377

UMMS Affiliation

Program in Gene Function and Expression; Program in Molecular Medicine

Date

2-3-2005

Document Type

Article

Subjects

Animals; Antigens, Viral, Tumor; Carcinoma, Hepatocellular; Cathepsin E; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, p53; Insulin-Like Growth Factor II; Liver Neoplasms, Experimental; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Mutation; Polyomavirus; Retroviridae

Disciplines

Life Sciences | Medicine and Health Sciences

Abstract

We have generated a mouse model for hepatocellular carcinoma using somatic delivery of oncogene-bearing avian retroviral vectors to the liver cells of mice expressing the viral receptor TVA under the control of the albumin gene promoter (Alb-TVA mice). Viruses encoding mouse polyoma virus middle T antigen (PyMT) induced tumors, which can be visualized with magnetic resonance imaging, in 65% of TVA-positive animals. While these tumors can exceed 10 mm in diameter, they do not invade locally or metastasize to the lungs. Delivery of PyMT-expressing viruses to Alb-TVA mice lacking an intact p53 gene does not increase tumor incidence. However, the resulting tumors are poorly differentiated, invasive, and metastatic to the lungs. Gene expression microarrays identified over 100 genes that are differentially expressed between tumors found in p53 wild-type and p53 null mice. Some of these genes, such as cathepsin E and Igf2, have been previously implicated in tumor cell migration and invasion. Tumors induced in p53 null, TVA transgenic mice by PyMT mutants with changes in specific tyrosine residues fail to form metastases, indicating that metastasis is dependent on both the oncogene and the absence of p53.

Rights and Permissions

Citation: Mol Cell Biol. 2005 Feb;25(4):1228-37. Link to article on publisher's site

Related Resources

Link to Article in PubMed